纤溶酶原激活物抑制剂-1与脑梗死相关性的研究进展
被引量:1
摘要
纤溶酶原激活物抑制剂-1(PAI-1)是tPA和uPA的主要抑制剂。PAI-1受PAI-1 基因调控,并受多种因素的影响。PAI-1在纤溶系统中起重要作用,与脑梗死的发生、发展和恢复有着密切的关系。PAI-1抑制剂也许可以提供与抗血小板药或抗凝药不同机制的新的抗血栓药。
出处
《神经疾病与精神卫生》
2005年第3期224-227,共4页
Journal of Neuroscience and Mental Health
参考文献32
-
1Levi M, Biemond BJ, Van Zonneveld A J, et al. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis[J]. Circulation,1992,85(1) :305-312.
-
2Hekman CM,Loskutoff DJ. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator[J]. Arch Biochem Biophys,1988,262:199-210.
-
3Loskutoff DJ,Curriden SA,Hu G,et al. Regulation of cell adhesion by PAI-1[J]. APMIS,1999,107 (1) :54-61.
-
4Schafer K, Konstantinides S. PAI- 1 and vasculopathy: the debate continues[J]. J Thromb Haemost, 2004,2 (1): 13- 15.
-
5Nordt TK,Lobrmann J,Bode C. Regulation of PAI- 1 Expression by Genetic Polymorphisms Impact on Atherogenesis[J]. Thromb Res, 2001,103(Sup): 1- 5.
-
6Eriksson P,Kallin B,Van't Hooft FM,et al. Allele-specific increasein basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardial infarction[J]. Proc Natl Acad Sci USA,1995,92:1 851-1 855.
-
7McCormack LJ,Semple JI,Stickland MH, et al. The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells[J]. Thromb Res, 1998,92(5) :199-206.
-
8Eriksson P, Nilsson L, Karpe F. Very- low- density lipoprotein response element in the promoter region of the humam plasminogen activator inhibitor- 1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia [J]. Arterioscler Thromb Vasc Biol, 1998,18 (1): 20- 26.
-
9Menges T,Hermans PW,Little SG,et al. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients[J]. Lancet, 2001, 357 (9262):1 096-1 097.
-
10Grenett HE,Benza RL,Li XN,et al. Expression of plasminogen activator inhibitor type Ⅰ in genotyped human endothelial cell cultures: genotype- specific regulation by insulin[J].Thromb Haemost,1999,82(5) :1 504-1 509.
同被引文献26
-
1陈立云,王拥军,赵性泉.脑梗死后出血性转化的研究进展[J].中国卒中杂志,2006,1(12):904-906. 被引量:33
-
2全冠民,袁涛,刘怀军.急性脑梗死出血性转化及MRI评估[J].国外医学(临床放射学分册),2006,29(5):311-314. 被引量:21
-
3雷惠新,汪效松,张旭,程琼,周秀珍.急性脑血管病患者血浆t-PA、PAI-1活性测定及意义[J].卒中与神经疾病,2007,14(2):73-75. 被引量:5
-
4Hamann GF,Okada Y,Fitridge R,et al.Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion[J].Stroke,1995,26(20):2 120-2 126.
-
5Okada Y,Copeland BR,Fitridge R,et al.Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion[J].Stroke,1994,25(9):1 847-1 853.
-
6Barr TL,Latour LL,Lee KY,et al.Blood brain barrier disruption in humans is independently associated with increased matrix metalloproteinase 9[J].Stroke,2010,41(3):e123-e128.
-
7Machado LS,Sazonova I,Kozak A,et al.Minocycline and tissue plasminogen activator for stroke:Assessment of interaction potential[J].Stroke,2009,40(9):3 028-3 033.
-
8Kelly MA,Shuaib A,Todd KG,et al.Matrix metalloproteinase activation and blood brain barrier breakdown following thrombolysis[J].Exp Neurol,2006,200(1):38-49.
-
9Castellanos M,Sobrino T,Millan M,et al.Serum cellular fibronectin and matrix metalloproteinase 9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke:a multicenter confirmatory study[J].Stroke,2007,38(6):1 855-1 859.
-
10Ning M,Furie KL,Koroshetz WJ,et al.Association between tPA therapy and raised early matrix metalloproteinase 9 in acute stroke[J].Neurology,2006,66(10):1 550-1 555.
二级引证文献7
-
1田洪,刘磊,郝磊,臧巧利,朱川.急性脑梗死后出血性转化48例临床特点分析[J].重庆医学,2015,44(2):183-185. 被引量:20
-
2翁优儿,曹东.脑梗死出血转化398例的危险因素分析及护理对策[J].护理与康复,2016,15(2):126-128. 被引量:1
-
3李倩.纤溶酶注射液在脑梗死急性期治疗效果的评价[J].中外医学研究,2017,15(33):66-67. 被引量:1
-
4张明山,许志强,张富山.脑梗死出血性转化的时间规律及MRI分型建议[J].西南国防医药,2018,28(6):519-521. 被引量:3
-
5陈宏,詹自雄,汪银洲,张旭,郑峥.影响非溶栓性脑梗死出血转化相关因素的临床分析[J].深圳中西医结合杂志,2018,28(15):9-12. 被引量:2
-
6中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,刘鸣,崔丽英.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志,2019,52(4):252-265. 被引量:3164
-
7罗军,梅承艳.老年急性脑梗死静脉溶栓患者院内出血转化Nomogram模型构建及预警防控的相关对策[J].中国医院统计,2025,32(5):360-364.
-
1寇海林,鹿育萨,张雪娥.同型半胱氨酸及PAI-1与缺血性脑血管病[J].医学综述,2006,12(14):837-840.
-
2赖晓辉,张清华,李运田,蒋知新.C反应蛋白对人脐静脉内皮细胞释放ET-1、PAI-1的影响[J].中国医药导刊,2004,6(6):396-397. 被引量:2
-
3崔岗,周岱,李金泉,蒋栋毅.蛛网膜下腔出血患者血浆PAI-1的浓度变化[J].中国血液流变学杂志,2001,11(4):318-320.
-
4严为宏.纤溶酶原激活物抑制剂-1与脑梗死的发生和预后[J].血栓与止血学,2003,9(1):35-36. 被引量:3
-
5胡均培,严为宏,邹丽芳,窦红菊,庄衍,程毅敏.脑梗死患者纤溶酶原激活物抑制剂-1 4G/5G基因多态性的研究[J].血栓与止血学,2005,11(3):112-113. 被引量:1
-
6刘洲,赵斌.纤溶酶原激活物抑制剂-1-675 4G/5G基因及纤维蛋白原β-148C/T基因多态性与脑梗死关系的研究[J].神经疾病与精神卫生,2008,8(2):94-97.
-
7梁彦涛,赵敬富,张敬军.纤维蛋白原与缺血性脑卒中的研究进展[J].中国临床神经科学,2007,15(5):558-560. 被引量:7
-
8王丽,耿荣,杨明.缺血性脑损伤的脑保护剂研究进展[J].实用心脑肺血管病杂志,2009,17(11):1018-1020. 被引量:4
-
9梁辉,范金英,朱海波,王敏,李强,周盛年.大鼠局灶性脑缺血再灌注血管内皮生长因子的表达变化及意义[J].中国神经免疫学和神经病学杂志,2008,15(6):450-452. 被引量:2
-
10吴国友,吕远栋,刘小利,周欢琴,翁秀妹,李萌.急性脑梗死患者血浆t-PA、PAI-1水平及血液流变学指标变化的相关性分析[J].心脑血管病防治,2011,11(2):117-119. 被引量:4